Sarepta Therapeutics (SRPT) reported $413.46 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 63.1%. EPS of $0.73 for the same period compares to -$0.97 a...
Source LinkSarepta Therapeutics (SRPT) reported $413.46 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 63.1%. EPS of $0.73 for the same period compares to -$0.97 a...
Source Link
Comments